Concepedia

Michael Brands

MB

Statistics

Publications

32

Citations

1.9K

H-Index

21

Active since

1989

Affiliations

Bayer (Germany)(Current)

Bayer (United States)

University of Mississippi Medical Center

Goethe University Frankfurt

University of Göttingen

Michael Brands is an author at Bayer (Germany) specializing in pharmacology, drug discovery, and medicinal chemistry.

Publications per year

1989–2020

32

Publications

32

Identification and Characterization of the First Class of Potent Bacterial Acetyl-CoA Carboxylase Inhibitors with Antibacterial Activity

Christoph Freiberg, Nina Brunner, Guido Schiffer et al. · Journal of Biological Chemistry · 2004 · 216 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

The Novel ATR Inhibitor BAY 1895344 Is Efficacious as Monotherapy and Combined with DNA Damage–Inducing or Repair–Compromising Therapies in Preclinical Cancer Models

Antje M. Wengner, Gerhard Siemeister, Ulrich Lücking et al. · Molecular Cancer Therapeutics · 2019 · 210 citations

Medicine, Molecular Biology, Oncology +17

Hypertension in Obese Zucker Rats

Magdalena Alonso‐Galicia, Michael Brands, Dion Zappe et al. · Hypertension · 1996 · 200 citations

Medicine, Pharmacology, Physiology +16

Identification of Atuveciclib (BAY 1143572), the First Highly Selective, Clinical PTEFb/CDK9 Inhibitor for the Treatment of Cancer

Ulrich Lücking, Arne Scholz, Philip Lienau et al. · ChemMedChem · 2017 · 184 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Novel Mps1 Kinase Inhibitors with Potent Antitumor Activity

Antje M. Wengner, Gerhard Siemeister, Marcus Koppitz et al. · Molecular Cancer Therapeutics · 2016 · 118 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 32